@inproceedings{inproceedings, title  = {{A cost-utility analysis of nilotinib for CML patients who have become resistant to imatinib}},

 url = {{}},

 year = {{2008}},

 month = {{4}},

 author = {{Jewitt K and Pilgrim H and Ward S}},

 volume = {{141}},

 journal = {{BRITISH JOURNAL OF HAEMATOLOGY}},

 pages = {{38-38}},

 note = {{Accessed on 2025/04/05}}}